How rogue immune cells cross the blood-brain barrier to cause multiple sclerosisDrug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to...
Every Connection Counts during MS Awareness Week, March 11-17/About-the-Society/News/Every-Connection-Counts-during-MS-Awareness-Week, … read morePosted At: National MS Society
The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis
The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosisMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Resistance Training May Slow MS, Study SaysScans revealed less brain shrinkage in exercise groupSource: HealthDay … read morePosted At: Medline Plus
First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria … read morePosted At: National MS Society
- Next story Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
- Previous story Cognitive fatigue after TBI linked with activation of caudate
Join Our Mailing List
- Sheep disease toxin shines a light on multiple sclerosis
- Guidelines Released by AAN to Help Inform Treatment Choices for Multiple Sclerosis
- Why are my legs and feet numb?
- MS News from the AAN Meeting in Los Angeles
- How to beat psoriasis at its own game
- How can CBD help with fibromyalgia?
- Physical and mental benefits of swimming
- National MS Society Commits $14.2 Million to New Research to Stop Multiple Sclerosis, Restore Functi
- Novel PET imaging agent could help guide therapy for brain diseasesPosted At: Science Daily
- 2018 John Dystel Prize for MS Research Goes to Prof. Frederik Barkhof – A Leader in Using MRI to St